US Stock MarketDetailed Quotes

GRCE Grace Therapeutics

Watchlist
  • 2.400
  • -0.140-5.51%
Close Mar 10 16:00 ET
  • 2.500
  • +0.100+4.17%
Post 18:57 ET
32.92MMarket Cap-2.09P/E (TTM)

Grace Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
21.72%3.7M
130.93%4.83M
67.16%4.96M
-37.70%11.37M
-21.66%3.26M
-28.32%3.04M
-59.04%2.09M
-37.23%2.97M
18.95%18.25M
-5.41%4.17M
Selling and administrative expenses
-5.69%1.51M
13.61%1.85M
20.47%2.25M
-19.09%6.64M
-38.67%1.54M
-9.86%1.6M
-10.78%1.63M
-10.65%1.87M
-16.04%8.21M
21.14%2.52M
-Selling and marketing expense
----
----
----
42.65%194K
----
----
----
----
17.24%136K
34.21%51K
-General and administrative expense
-5.69%1.51M
13.61%1.85M
20.47%2.25M
-20.13%6.45M
-45.27%1.35M
-6.05%1.6M
-10.63%1.63M
-10.22%1.87M
-16.44%8.08M
20.89%2.47M
Research and development costs
52.04%2.19M
546.96%2.98M
147.31%2.71M
-53.04%4.68M
2.74%1.69M
-41.10%1.44M
-86.03%460K
-57.72%1.1M
79.38%9.97M
-29.49%1.64M
Depreciation amortization depletion
--1K
100.00%2K
-66.67%1K
-36.51%40K
288.89%35K
--0
108.33%1K
-93.48%3K
--63K
--9K
-Depreciation and amortization
--1K
100.00%2K
-66.67%1K
-36.51%40K
288.89%35K
--0
108.33%1K
-93.48%3K
--63K
--9K
Operating profit
-21.72%-3.7M
-130.93%-4.83M
-67.16%-4.96M
37.70%-11.37M
21.66%-3.26M
28.32%-3.04M
59.04%-2.09M
37.23%-2.97M
-18.95%-18.25M
5.41%-4.17M
Net non-operating interest income expense
-56.33%138K
-18.87%172K
75.37%235K
270.33%911K
122.32%249K
371.64%316K
488.89%212K
318.75%134K
219.48%246K
198.25%112K
Non-operating interest income
-56.33%138K
-18.87%172K
75.37%235K
270.33%911K
122.32%249K
371.64%316K
488.89%212K
318.75%134K
219.48%246K
198.25%112K
Other net income (expense)
-1,032.81%-1.19M
120.39%375K
193.91%1.39M
87.55%-4.23M
96.93%-1.04M
753.33%128K
-15,225.00%-1.84M
-2,072.06%-1.48M
-808.30%-33.97M
-96,771.43%-33.91M
Gain on sale of security
-1,032.81%-1.19M
120.39%375K
17,237.50%1.39M
-4,325.81%-2.74M
-34,800.00%-1.04M
753.33%128K
-15,225.00%-1.84M
111.76%8K
-101.27%-62K
101.65%3K
Special income (charges)
--0
--0
--0
95.62%-1.49M
--0
--0
--0
---1.49M
-13,517.67%-33.91M
---33.91M
-Less:Restructuring and merger&acquisition
--0
--0
--0
--1.49M
--0
--0
--0
--1.49M
--0
--0
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--33.51M
----
-Write off
----
----
----
--0
----
----
----
----
60.64%400K
----
Income before tax
-83.15%-4.76M
-15.19%-4.28M
22.52%-3.34M
71.74%-14.69M
89.32%-4.06M
37.57%-2.6M
26.85%-3.72M
9.53%-4.31M
-396.52%-51.97M
-733.88%-37.96M
Income tax
-190.87%-605K
-91.03%-852K
-150.52%-724K
80.80%-1.83M
89.98%-889K
24.09%-208K
-187.74%-446K
-19.42%-289K
-1,372.53%-9.54M
-1,268.98%-8.87M
Net income
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-332.11%-42.43M
-645.06%-29.09M
Net income continuous Operations
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-332.11%-42.43M
-645.06%-29.09M
Minority interest income
Net income attributable to the parent company
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-332.11%-42.43M
-645.06%-29.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
38.52%-2.39M
33.60%-3.27M
11.07%-4.02M
-332.11%-42.43M
-645.06%-29.09M
Basic earnings per share
-71.43%-0.36
30.23%-0.3
55.56%-0.24
69.70%-1.73
83.63%-0.64
59.62%-0.21
34.85%-0.43
11.48%-0.54
-252.47%-5.71
-639.27%-3.91
Diluted earnings per share
-71.43%-0.36
30.23%-0.3
55.56%-0.24
69.70%-1.73
83.63%-0.64
59.62%-0.21
34.85%-0.43
11.48%-0.54
-252.47%-5.71
-639.27%-3.91
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 21.72%3.7M130.93%4.83M67.16%4.96M-37.70%11.37M-21.66%3.26M-28.32%3.04M-59.04%2.09M-37.23%2.97M18.95%18.25M-5.41%4.17M
Selling and administrative expenses -5.69%1.51M13.61%1.85M20.47%2.25M-19.09%6.64M-38.67%1.54M-9.86%1.6M-10.78%1.63M-10.65%1.87M-16.04%8.21M21.14%2.52M
-Selling and marketing expense ------------42.65%194K----------------17.24%136K34.21%51K
-General and administrative expense -5.69%1.51M13.61%1.85M20.47%2.25M-20.13%6.45M-45.27%1.35M-6.05%1.6M-10.63%1.63M-10.22%1.87M-16.44%8.08M20.89%2.47M
Research and development costs 52.04%2.19M546.96%2.98M147.31%2.71M-53.04%4.68M2.74%1.69M-41.10%1.44M-86.03%460K-57.72%1.1M79.38%9.97M-29.49%1.64M
Depreciation amortization depletion --1K100.00%2K-66.67%1K-36.51%40K288.89%35K--0108.33%1K-93.48%3K--63K--9K
-Depreciation and amortization --1K100.00%2K-66.67%1K-36.51%40K288.89%35K--0108.33%1K-93.48%3K--63K--9K
Operating profit -21.72%-3.7M-130.93%-4.83M-67.16%-4.96M37.70%-11.37M21.66%-3.26M28.32%-3.04M59.04%-2.09M37.23%-2.97M-18.95%-18.25M5.41%-4.17M
Net non-operating interest income expense -56.33%138K-18.87%172K75.37%235K270.33%911K122.32%249K371.64%316K488.89%212K318.75%134K219.48%246K198.25%112K
Non-operating interest income -56.33%138K-18.87%172K75.37%235K270.33%911K122.32%249K371.64%316K488.89%212K318.75%134K219.48%246K198.25%112K
Other net income (expense) -1,032.81%-1.19M120.39%375K193.91%1.39M87.55%-4.23M96.93%-1.04M753.33%128K-15,225.00%-1.84M-2,072.06%-1.48M-808.30%-33.97M-96,771.43%-33.91M
Gain on sale of security -1,032.81%-1.19M120.39%375K17,237.50%1.39M-4,325.81%-2.74M-34,800.00%-1.04M753.33%128K-15,225.00%-1.84M111.76%8K-101.27%-62K101.65%3K
Special income (charges) --0--0--095.62%-1.49M--0--0--0---1.49M-13,517.67%-33.91M---33.91M
-Less:Restructuring and merger&acquisition --0--0--0--1.49M--0--0--0--1.49M--0--0
-Less:Impairment of capital assets --------------0------------------33.51M----
-Write off --------------0----------------60.64%400K----
Income before tax -83.15%-4.76M-15.19%-4.28M22.52%-3.34M71.74%-14.69M89.32%-4.06M37.57%-2.6M26.85%-3.72M9.53%-4.31M-396.52%-51.97M-733.88%-37.96M
Income tax -190.87%-605K-91.03%-852K-150.52%-724K80.80%-1.83M89.98%-889K24.09%-208K-187.74%-446K-19.42%-289K-1,372.53%-9.54M-1,268.98%-8.87M
Net income -73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M38.52%-2.39M33.60%-3.27M11.07%-4.02M-332.11%-42.43M-645.06%-29.09M
Net income continuous Operations -73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M38.52%-2.39M33.60%-3.27M11.07%-4.02M-332.11%-42.43M-645.06%-29.09M
Minority interest income
Net income attributable to the parent company -73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M38.52%-2.39M33.60%-3.27M11.07%-4.02M-332.11%-42.43M-645.06%-29.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M38.52%-2.39M33.60%-3.27M11.07%-4.02M-332.11%-42.43M-645.06%-29.09M
Basic earnings per share -71.43%-0.3630.23%-0.355.56%-0.2469.70%-1.7383.63%-0.6459.62%-0.2134.85%-0.4311.48%-0.54-252.47%-5.71-639.27%-3.91
Diluted earnings per share -71.43%-0.3630.23%-0.355.56%-0.2469.70%-1.7383.63%-0.6459.62%-0.2134.85%-0.4311.48%-0.54-252.47%-5.71-639.27%-3.91
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--